Stay updated with breaking news from Multiple Sclerosis Research Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with teriflunomide resulted in a 63% risk reduction relative to placebo in preventing the first symptoms of multiple sclerosis in individuals with radiologically isolated syndrome.
New study sheds light on psychiatric conditions that appear in the years prior to multiple sclerosis symptoms.
/PRNewswire/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced...